Tag: CDY
Cellmid set to commercialise 15 minute diagnostic test for COVID-19
Life sciences company Cellmid (ASX: CDY) is set to come out of its self-imposed trading halt on Monday with news that it will commercialise a rapid test capable of detecting coronavirus (COVID-19) wit...
Cellmid prepares to receive Chinese patent covering évolis range
Life sciences company Cellmid (ASX: CDY) has told the market it is tentatively expecting to receive a patent from the Chinese Patent Office for its évolis brand in the very near future.
Earlier tod...
Cellmid launches evolis hair products into Europe and China via new distribution agreements
Cellmid (ASX: CDY) has launched into Europe after securing a distribution agreement with Douglas GmbH for its evolis professional anti-aging hair care and hair loss products, while at the same time co...
Cellmid predicts record second quarter revenue after successful Japanese sales campaign
Australian life sciences company Cellmid (ASX: CDY) has reaped a revenue of approximately $1.1 million from a scheduled sales event for its Jo-Ju hair growth products in Japan.
The figure will cont...
Cellmid’s anti-midkine study holds promise for chronic kidney disease patients
Australian life sciences company Cellmid (ASX: CDY) has announced positive efficacy results of a study using its anti-midkine antibody CAB102 in the treatment of rare kidney disease focal segmental gl...
Cellmid executes pincer movement to distribute cornerstone évolis product into both China and the US
With the US-China trade war brewing in the background, life sciences company Cellmid (ASX: CDY) has secured a deal to sell its évolis product in China – barely a week after agreeing to supply the same...
Cellmid agrees distribution deal with Bloomingdale’s to stock évolis professional range
Life sciences company Cellmid (ASX: CDY) has secured a potentially money-spinning partnership with Bloomingdale's, a prominent US retailer, for the sale of its évolis product range.
Bloomingdale's’...
Positive study results for Cellmid’s évolis hair growth products
Cellmid Limited (ASX: CDY) has reported positive results following the completion of its first consumer experience study using the evolis® Professional product range.
All but one of the study parti...
